Premier Dental Products Company
$182.7K 1,456 recipients
Compare payment profiles
CMS Open Payments · Program Year 2024
FUJIFILM Corporation
FUJIFILM Corporation reported $182,655.93 across General Payments, Research, and Ownership to 22 physicians and teaching hospitals across 23 transactions.
- $182.7K
- All-tracks total
- 23
- Transactions
- 22
- Recipients
- +$77.7K
- General Payments vs PY2023
FUJIFILM Corporation reported $182,655.93 across all CMS Open Payments tracks (General + Research + Ownership) to 22 physicians and teaching hospitals in Program Year 2024 - ranking #1033 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $77,805.93, averaging $8.3K per recipient.
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer fujifilm-corporation FUJIFILM Corporation
$182.7K · #1033/1,925 · 0.0% industry · PY2024
- TOT $182.7K
- RANK #1033
- SHARE 0.0%
- TXN 23
- RCP 22
- CAT 3
- GEN $77.8K
- ΔGEN +$77.7K
- TOP1 27.6%
- PY 2024
Volume peers
Nearest volume peer: Premier Dental Products Company ($182.7K)
FUJIFILM Corporation sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
FUJIFILM Corporation's CMS-reported General Payments increased by $77.7K (+87618.1%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2023: FUJIFILM CORPORATIONPY2024: FUJIFILM Corporation. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $88.70
- PY2024
- $77,805.93
What the Data Shows for FUJIFILM Corporation
In Program Year 2024, FUJIFILM Corporation reported $182,655.93 in payments to 22 physicians and teaching hospitals across 23 individual transactions, an average of $7.9K per transaction and $8.3K per recipient. That total places FUJIFILM Corporation at rank #1033 out of 1,925 companies in the CMS Open Payments database, a comparatively small 0.0% slice of all industry payments reported nationwide for the year.
6 transactions worth $60.5K make "Consulting Fee" the top general-payment category in the 3-category breakdown below, 77.8% of General Payments (see our methodology for how research and ownership payments are reported separately).
General Payment Breakdown by Type
FUJIFILM Corporation made 3 types of general payments. "Consulting Fee" is the largest category at $60.5K, 77.8% of General Payments.
How FUJIFILM Corporation divides its payments
Ranked by total dollars reported per category
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Consulting Fee | $60.5K | 6 | 77.8% |
| Travel and Lodging | $16.8K | 2 | 21.6% |
| Gift | $491.62 | 14 | 0.6% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $73,814.31 (94.9%) of $77,805.93 in this company's General Payments records across 13 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for FUJIFILM Corporation
The five named recipients with the highest reported General Payments from this company
- 1
Jeffrey Mahony
$21,500.00 across 1 reported transactions
- 2
Amit Singal
$16,814.31 across 2 reported transactions
- 3
Robert Garth Eberly
$15,500.00 across 2 reported transactions
- 4
Dana Fathy
$13,000.00 across 1 reported transactions
- 5
Gregory James Minwell
$7,000.00 across 1 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as FUJIFILM Corporation's, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about FUJIFILM Corporation.
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with FUJIFILM Corporation.
Showing 6 of 1,924 companies with CMS-reported payment data.
Accord Healthcare, Inc.
$183.2K 4,160 recipients
Compare payment profiles
Ultrasight Inc
$183.8K 54 recipients
Compare payment profiles
RedDress USA, Inc.
$184.0K 225 recipients
Compare payment profiles
Ambu A/S
$181.1K 129 recipients
Compare payment profiles
Bisco, Inc.
$180.9K 184 recipients
Compare payment profiles
Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.